0001567619-20-016966.txt : 20200922 0001567619-20-016966.hdr.sgml : 20200922 20200922121015 ACCESSION NUMBER: 0001567619-20-016966 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200922 DATE AS OF CHANGE: 20200922 EFFECTIVENESS DATE: 20200922 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Focus-X Therapeutics, Inc. CENTRAL INDEX KEY: 0001825529 IRS NUMBER: 852483901 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-375977 FILM NUMBER: 201188709 BUSINESS ADDRESS: STREET 1: 3541 223RD AVE. SE. CITY: SAMMAMISH STATE: WA ZIP: 98075 BUSINESS PHONE: 3175694884 MAIL ADDRESS: STREET 1: 3541 223RD AVE. SE. CITY: SAMMAMISH STATE: WA ZIP: 98075 D 1 primary_doc.xml X0708 D LIVE 0001825529 Focus-X Therapeutics, Inc. 3541 223RD AVE. SE. SAMMAMISH WA WASHINGTON 98075 3175694884 DELAWARE None None Corporation true 2020 Fa Liu 3541 223rd Ave SE Sammamish WA WASHINGTON 98705 Executive Officer Director Qi Hui 3541 223rd Ave SE Sammamish WA WASHINGTON 98705 Executive Officer Director Other Technology Decline to Disclose 06b false 2020-09-09 false true false 0 3000000 1500000 1500000 false 1 0 0 0 false Focus-X Therapeutics, Inc. David Bartoletti David Bartoletti Authorized Representative Power of Attorney previously filed 2020-09-22